CWA
ZYME icon

Capital Wealth Alliance’s Zymeworks ZYME Stock Holding History

Capital Wealth Alliance’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-550
Closed -$24K – 362
2019
Q4 		$24K Buy
+550
New +$20K 0.02% 170

Other funds holding ZYME

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Capital Wealth Alliance's ZYME Position: Q1 2020 in Review

Capital Wealth Alliance sold out of Zymeworks (ZYME) in Q1 2020, closing a stake of 550 shares — an estimated $24K sold.

Capital Wealth Alliance first reported a position in ZYME in Q4 2019 and held it in 1 quarter. The position peaked at $24K in Q4 2019. 116 funds tracked by Wall St. Rank hold ZYME as of Q1 2020.

  • Capital Wealth Alliance reported no remaining Zymeworks position as of Q1 2020 after selling out during the quarter.
  • Capital Wealth Alliance sold 550 Zymeworks shares in Q1 2020, an estimated $24K.
  • Capital Wealth Alliance first reported a position in Zymeworks in Q4 2019 and held it in 1 quarter.
  • Capital Wealth Alliance's Zymeworks position peaked at $24K in Q4 2019.
  • 116 funds tracked by Wall St. Rank held Zymeworks as of Q1 2020.

Based on Capital Wealth Alliance's 13F filing for Q1 2020, filed 28 Apr 2020.